Do you want to read an article? Please log in or register.
TP53-associated early breast cancer: new observations from a large cohort
Breast Cancer
Related content
Breast Cancer
Breast Cancer Index in Premenopausal Women With Early-Stage Hormone Receptor-Positive Breast Cancer
JAMA Oncol
O'Regan RM, Zhang Y, Fleming GF, Francis PA, Kammler R, Viale G, Dell'Orto P, Lang I, Bellet M, Bonnefoi HR, Tondini C, Villa F, Bernardo A, Ciruelos EM, Neven P, Karlsson P, Müller B, Jochum W, Zaman K, Martino S, Geyer CE Jr, Jerzak KJ, Davidson NE, Coleman RE, Ingle JN, van Mackelenbergh MT, Loi S, Colleoni M, Schnabel CA, Treuner K, Regan MM
doi: 10.1001/jamaoncol.2024.3044
Gastrointestinal Cancer
Associations between degree of food processing and colorectal cancer risk in a large-scale European cohort
Int J Cancer
Al Nahas A, Yammine Ghantous S, Morales Berstein F, Cakmak EK, Biessy C, Nicolas G, Kliemann N, Lopez JB, Jacobs I, Gonzalez-Gil EM, Cairat M, Pinho MGM, Bertazzi Levy R, Rauber F, Vamos EP, Chang K, Millett C, Touvier M, Kesse-Guyot E, Severi G, Marques C, Hajji M, Macciotta A, Masala G, Fordellone M, Agnoli C, Amiano P, Guevara M, Tjønneland A, Kyrø C, Derksen JWG, Smit KC, Schulze MB, Jannasch F, Kaaks R, Katzke V, Braaten T, Brustad M, Skeie G, Harewood R, Heath A, Vineis P, Weiderpass E, Ferrari P, Gunter MJ, Huybrechts I
doi: 10.1002/ijc.35361
Breast Cancer
Postoperative radiotherapy in women with early operable breast cancer (Scottish Breast Conservation Trial): 30-year update of a randomised, controlled, phase 3 trial
Lancet Oncol
Williams LJ, Kunkler IH, Taylor KJ, Dunlop J, Piper T, Caldwell J, Jack W, Loane JF, Elder K, Bartlett JMS, Dixon JM, Cameron DA
doi: 10.1016/S1470-2045(24)00347-4
RECOMMENDED
Breast Cancer
Single-modality endocrine therapy versus radiotherapy after breast-conserving surgery in women aged 70 years and older with luminal A-like early breast cancer (EUROPA): a preplanned interim analysis of a phase 3, non-inferiority, randomised trial
★ 3
Recommended by
Dr Andreas Müller, Faculty Member
Lancet Oncol
Meattini I, De Santis MC, Visani L, Scorsetti M, Fozza A, Meduri B, De Rose F, Bonzano E, Prisco A, Masiello V, La Rocca E, Spoto R, Becherini C, Blandino G, Moscetti L, Colciago RR, Audisio RA, Brain E, Caini S, Hamaker M, Kaidar-Person O, Lambertini M, Marrazzo L, Saieva C, Spanic T, Strnad V, Wheelwright S, Poortmans PMP, Livi L, EUROPA Trial Investigators
doi: 10.1016/S1470-2045(24)00661-2
Breast Cancer
Second Primary Breast Cancer in Young Breast Cancer Survivors
JAMA Oncol
Brantley KD, Rosenberg SM, Collins LC, Ruddy KJ, Tamimi RM, Schapira L, Borges VF, Warner E, Come SE, Zheng Y, Kirkner GJ, Snow C, Winer EP, Partridge AH
doi: 10.1001/jamaoncol.2024.0286
SABCS 2024
Breast Cancer
OlympiA: Olaparib continues to demonstrate improved OS, IDFS and DDFS in patients with BRCA1/2-mutated HER2-negative high-risk early breast cancer
Lung, Respiratory and Thoracic Cancer
Outcomes After Surgical Management of Early-Stage Lung Cancer in Octogenarians: An in-depth Analysis of a Nationally Representative Cohort
J Thorac Oncol
Bostock IC, Fox AH, Ward RC, Engelhardt KE, Farjah F, Jeffrey Yang CF, Smith RA, Gibney BC, Silvestri GA, American Cancer Society National Lung Cancer Roundtable (NLCRT)
doi: 10.1016/j.jtho.2025.01.020
ASCO 2024
Breast Cancer
monarchE: ctDNA detection is highly prognostic of worse clinical outcomes in patients with HR-positive, HER2-negative, lymph node-positive early breast cancer
Lung, Respiratory and Thoracic Cancer
Neoadjuvant and Adjuvant Treatment for Early-Stage Resectable Non-small Cell Lung Cancer (NSCLC): Consensus Recommendations from the International Association for the Study of Lung Cancer (IASLC)
J Thorac Oncol
Spicer JD, Cascone T, Wynes MW, Ahn MJ, Dacic S, Felip E, Forde PM, Higgins KA, Kris MG, Mitsudomi T, Provencio M, Senan S, Solomon BJ, Tsao MS, Tsuboi M, Wakelee HA, Wu YL, Chih-Hsin Yang J, Zhou C, Harpole DH, Kelly KL
doi: 10.1016/j.jtho.2024.06.010